BCC Research Report Indicates Global Market for Excipient Chemicals Worth $4.3 Billion by 2011.WELLESLEY, Mass. -- According to a new technical market research report, EXCIPIENTS excipients, n.pl all the constituents of a remedy that lack medicinal properties. See also adjuvant, auxiliary substance, and vehicle. IN PHARMACEUTICALS (PHM010E) from BCC (Blind Carbon Copy) The field in an e-mail header that names additional recipients for the message. It is similar to carbon copy (cc), but the names do not appear in the recipient's message. Not all e-mail systems support the bcc feature. See fcc. Research (www.bccresearch.com), the global market for excipient excipient /ex·cip·i·ent/ (ek-sip´e-int) any more or less inert substance added to a drug to give suitable consistency or form to the drug; a vehicle. ex·cip·i·ent n. chemicals was worth $3.5 billion in 2006. This is expected to increase to over $4.3 billion by 2011, for a compound annual growth rate (CAGR CAGR See: Compound Annual Growth Rate ) of 3.8%. The market is broken down into applications of organic, inorganic and United States Pharmacopeia United States Pharmacopeia /Unit·ed States Phar·ma·co·peia/ (USP) a legally recognized compendium of standards for drugs, published by The United States Pharmacopeial Convention, Inc., and revised periodically. (USP USP - unique sales point ) water chemicals. Of these, organic chemicals have the largest share of the market. Valued at nearly $3.1 billion in 2006, this segment is expected to be worth $3.7 billion by 2011, a CAGR of 3.8%. The second largest segment, inorganic chemicals, was worth an estimated $363 million in 2006 and will reach $434 million by 2011. USP water was a $68 million segment in 2006 that will be worth $89 million in 2011, a CAGR of 5.4%. Excipients perform definite and important functions that enhance the efficacy of the active pharmaceutical ingredients (APIs) in a finished product. The pharmaceutical industry is refining the physical structure of APIs and is designing them with more functionality. In some cases, the refinements will mean that fewer excipients are needed; in others, corresponding changes will occur with the functional categories, where some will become more prominent and some will decline. Refinements in APIs, for example, have brought about a downward shift for binders, which were once widely used. Advanced techniques also can affect the level of excipient usage. Nanocoatings, for example, reduce the amount of lubricants needed and do away with the need for wet granulation granulation /gran·u·la·tion/ (-shun) 1. the division of a hard substance into small particles. 2. the formation in wounds of small, rounded masses of tissue during healing; also the mass so formed. and compacting. Neither the API refinements nor the advanced techniques should have as pronounced an effect in the next 5 years as they will over the next decade. [TABLE OMITTED] Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research (www.bccresearch.com), 40 Washington Street, Suite 110, Wellesley, MA; Telephone: 866-285-7215, editor@bccresearch.com as the source and publisher, along with report number, which can be found immediately after the report title. Thank you. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion